Schedule 13G ownership disclosure

IKENA ONCOLOGY INC

Common Stock · CUSIP: 45175G108

Event date: 2024-12-31

Filing-level shares
1,521,312
Percent of class
3.6%
  • GILEAD SCIENCES INC

    Shares: 1,521,312 · Class: 3.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001123292-25-000081
Form type
SCHEDULE 13G/A
Filer
GILEAD SCIENCES, INC.
CIK
CIK 882095
Filed
Feb 13, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub